MetaStat, Inc. (OTCPK: MTST)
Health Care · Life Sciences Tools & Services · US
$—
— today · — 1Y
MetaStat, Inc. (OTCPK: MTST) operates in the Life Sciences Tools & Services industry within the Health Care sector. The company is valued at $5.88K and employs 6 people.
trading between 0.00 and 0.08.
Tweenvest scores MetaStat, Inc. across four factors: quality 3/100, value 57/100. Its strongest factor is value.
MTST price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $5.88K
- Revenue (TTM)
- $23.30K
- P/E
- —
- EPS
- -0.61
- Dividend yield
- —
- Beta (5Y)
- 290.96
- 52-week high
- $0.08
- 52-week low
- $0.00
- Avg volume (3M)
- —
- Shares outstanding
- 5.88M
- Employees
- 6
- Next earnings
- —
About MetaStat, Inc.
MetaStat, Inc., a precision medicine company, focuses on discovering and developing therapeutic and diagnostic treatment solutions for cancer patients. The company is developing novel drug candidates and companion diagnostic tests that target the MENA pathway. Its product candidates include MENA diagnostic assay, a tissue-based quantitative immunofluorescence test that measures expression of the pro-metastatic MENA protein splice-variant; companion diagnostic to predict RTK inhibitor drug responses and anti-microtubule drug responses; liquid blood-based biopsy to enhance cancer diagnosis and optimize patient care; MetaSite Breast assay, an immunohistochemistry test that measures micro-anatomical intravasat at blood vessels within the tumor microenvironment ion sites; and prognostic diagnostic to predict risk of cancer metastasis. The company’s therapeutic targets a critical metastatic pathway in solid tumors responsible for driving tumor resistance and the spread of aggressive cancer. MetaStat, Inc. is based in Boston, Massachusetts.
- ISIN
- US59140A2033
- Listed since
- Jan 5, 2009
- Exchange
- Pink Sheets LLC
- Currency
- USD
Other Life Sciences Tools & Services companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Thermo Fisher Scientific Inc.NYSE: TMO | $232.26B | $633.71 | +0.89% |
| Danaher CorporationNYSE: DHR | $151.82B | $215.36 | -0.28% |
| WuXi AppTec Co., Ltd.SHSE: 603259 | $71.35B | CN¥161.00 | +3.31% |
| Samsung Biologics Co.,Ltd.KOSE: A207940 | $51.75B | ₩1,551,000.00 | +0.19% |
| Lonza Group AGSWX: LONN | $51.65B | CHF587.80 | -1.01% |
| Agilent Technologies, Inc.NYSE: A | $43.71B | $155.08 | +0.20% |
| IQVIA Holdings Inc.NYSE: IQV | $42.70B | $261.51 | +0.81% |
| Waters CorporationNYSE: WAT | $40.72B | $414.17 | -0.07% |
Figures last refreshed Aug 18, 2026.